Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus

English version České info

Viruses that replicate in the host cell cytoplasm have evolved to employ host cell-derived membranes to compartmentalize genome replication and transcription. Specifically for positive-stranded RNA viruses, accumulating knowledge concerning the involvement, rearrangement and requirement of cellular membranes for RNA synthesis specify the establishment of the viral replicase complex at host cell-derived membranes as an evolutionary conserved and essential step in the early phase of the viral life cycle. Here we describe a small compound inhibitor of coronavirus replication that (i) specifically targets this membrane-bound RNA replication step and (ii) has broad antiviral activity against number of diverse coronaviruses including highly pathogenic SARS-CoV and MERS-CoV. Since resistance mutations appear in an integral membrane-spanning component of the coronavirus replicase complex, and since all positive stranded RNA viruses have very similar membrane-spanning or membrane-associated replicase components implicated in anchoring the viral replication complex to host cell-derived membranes, our data suggest that the membrane-bound replication step of the viral life cycle is a novel, vulnerable, and druggable target for antiviral intervention of a wide range of RNA virus infections.

Vyšlo v časopise: Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus. PLoS Pathog 10(5): e32767. doi:10.1371/journal.ppat.1004166
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004166

Souhrn

Zdroje

1. DrostenC, GuntherS, PreiserW, van der WerfS, BrodtHR, et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976.

2. KsiazekTG, ErdmanD, GoldsmithCS, ZakiSR, PeretT, et al. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348: 1953–1966.

3. PeirisJS, LaiST, PoonLL, GuanY, YamLY, et al. (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319–1325.

4. HamreD, ProcknowJJ (1966) A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 121: 190–193.

5. McIntoshK, DeesJH, BeckerWB, KapikianAZ, ChanockRM (1967) Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A 57: 933–940.

6. BerminghamA, ChandMA, BrownCS, AaronsE, TongC, et al. (2012) Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill 17: 20290.

7. van BoheemenS, de GraafM, LauberC, BestebroerTM, RajVS, et al. (2012) Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3: e00473–12.

8. ZakiAM, van BoheemenS, BestebroerTM, OsterhausAD, FouchierRA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367: 1814–1820.

9. PerlmanS, NetlandJ (2009) Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 7: 439–450.

10. YeagerCL, AshmunRA, WilliamsRK, CardellichioCB, ShapiroLH, et al. (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357: 420–422.

11. KunkelF, HerrlerG (1993) Structural and functional analysis of the surface protein of human coronavirus OC43. Virology 195: 195–202.

12. KuhnJH, LiW, ChoeH, FarzanM (2004) Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci 61: 2738–2743.

13. HofmannH, PyrcK, van der HoekL, GeierM, BerkhoutB, et al. (2005) Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A 102: 7988–7993.

14. RajVS, MouH, SmitsSL, DekkersDH, MullerMA, et al. (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495: 251–254.

15. DijkmanR, JebbinkMF, KoekkoekSM, DeijsM, JonsdottirHR, et al. (2013) Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol 87: 6081–6090.

16. CinatlJJr, MichaelisM, HoeverG, PreiserW, DoerrHW (2005) Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Res 66: 81–97.

17. GorbalenyaAE, KooninEV, DonchenkoAP, BlinovVM (1989) Coronavirus genome: prediction of putative functional domains in the non-structural polyprotein by comparative amino acid sequence analysis. Nucleic Acids Res 17: 4847–4861.

18. ZiebuhrJ, HeroldJ, SiddellSG (1995) Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity. J Virol 69: 4331–4338.

19. HeroldJ, GorbalenyaAE, ThielV, SchelleB, SiddellSG (1998) Proteolytic processing at the amino terminus of human coronavirus 229E gene 1-encoded polyproteins: identification of a papain-like proteinase and its substrate. J Virol 72: 910–918.

20. ZiebuhrJ, SchelleB, KarlN, MinskaiaE, BayerS, et al. (2007) Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication. J Virol 81: 3922–3932.

21. AnandK, PalmGJ, MestersJR, SiddellSG, ZiebuhrJ, et al. (2002) Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J 21: 3213–3224.

22. BachaU, BarrilaJ, Velazquez-CampoyA, LeavittSA, FreireE (2004) Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry 43: 4906–4912.

23. BlanchardJE, EloweNH, HuitemaC, FortinPD, CechettoJD, et al. (2004) High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem Biol 11: 1445–1453.

24. JainRP, PetterssonHI, ZhangJ, AullKD, FortinPD, et al. (2004) Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro. J Med Chem 47: 6113–6116.

25. RatiaK, PeganS, TakayamaJ, SleemanK, CoughlinM, et al. (2008) A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A 105: 16119–16124.

26. AnandK, ZiebuhrJ, WadhwaniP, MestersJR, HilgenfeldR (2003) Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300: 1763–1767.

27. ImbertI, GuillemotJC, BourhisJM, BussettaC, CoutardB, et al. (2006) A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus. EMBO J 25: 4933–4942.

28. GorbalenyaAE, EnjuanesL, ZiebuhrJ, SnijderEJ (2006) Nidovirales: evolving the largest RNA virus genome. Virus Res 117: 17–37.

29. AhlquistP (2006) Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses. Nat Rev Microbiol 4: 371–382.

30. den BoonJA, AhlquistP (2010) Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories. Annu Rev Microbiol 64: 241–256.

31. OverbyAK, PopovVL, NiedrigM, WeberF (2010) Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol 84: 8470–8483.

32. KnoopsK, KikkertM, WormSH, Zevenhoven-DobbeJC, van der MeerY, et al. (2008) SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 6: e226.

33. Romero-BreyI, MerzA, ChiramelA, LeeJY, ChlandaP, et al. (2012) Three-dimensional architecture and biogenesis of membrane structures associated with hepatitis C virus replication. PLoS Pathog 8: e1003056.

34. UlasliM, VerheijeMH, de HaanCA, ReggioriF (2010) Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell Microbiol 12: 844–861.

35. WelschS, MillerS, Romero-BreyI, MerzA, BleckCK, et al. (2009) Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe 5: 365–375.

36. BalijiS, CammerSA, SobralB, BakerSC (2009) Detection of nonstructural protein 6 in murine coronavirus-infected cells and analysis of the transmembrane topology by using bioinformatics and molecular approaches. J Virol 83: 6957–6962.

37. OostraM, HagemeijerMC, van GentM, BekkerCP, te LinteloEG, et al. (2008) Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol 82: 12392–12405.

38. GosertR, KanjanahaluethaiA, EggerD, BienzK, BakerSC (2002) RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol 76: 3697–3708.

39. Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ (2013) Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. MBio 4 : pii: e00524–13.

40. PrenticeE, JeromeWG, YoshimoriT, MizushimaN, DenisonMR (2004) Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 279: 10136–10141.

41. ReggioriF, MonastyrskaI, VerheijeMH, CaliT, UlasliM, et al. (2010) Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe 7: 500–508.

42. SnijderEJ, van der MeerY, Zevenhoven-DobbeJ, OnderwaterJJ, van der MeulenJ, et al. (2006) Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80: 5927–5940.

43. HagemeijerMC, RottierPJ, de HaanCA (2012) Biogenesis and dynamics of the coronavirus replicative structures. Viruses 4: 3245–3269.

44. ClementzMA, KanjanahaluethaiA, O'BrienTE, BakerSC (2008) Mutation in murine coronavirus replication protein nsp4 alters assembly of double membrane vesicles. Virology 375: 118–129.

45. GadlageMJ, SparksJS, BeachboardDC, CoxRG, DoyleJD, et al. (2010) Murine hepatitis virus nonstructural protein 4 regulates virus-induced membrane modifications and replication complex function. J Virol 84: 280–290.

46. CottamEM, MaierHJ, ManifavaM, VauxLC, Chandra-SchoenfelderP, et al. (2011) Coronavirus nsp6 proteins generate autophagosomes from the endoplasmic reticulum via an omegasome intermediate. Autophagy 7: 1335–1347.

47. ColeySE, LaviE, SawickiSG, FuL, SchelleB, et al. (2005) Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J Virol 79: 3097–3106.

48. TekesG, Hofmann-LehmannR, StallkampI, ThielV, ThielHJ (2008) Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol 82: 1851–1859.

49. CasaisR, ThielV, SiddellSG, CavanaghD, BrittonP (2001) Reverse genetics system for the avian coronavirus infectious bronchitis virus. J Virol 75: 12359–12369.

50. ThielV, IvanovKA, PuticsA, HertzigT, SchelleB, et al. (2003) Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol 84: 2305–2315.

51. KindlerE, JonsdottirHR, MuthD, HammingOJ, HartmannR, et al. (2013) Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio 4: e00611–00612.

52. van den WormSH, ErikssonKK, ZevenhovenJC, WeberF, ZustR, et al. (2012) Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. PLoS One 7: e32857.

53. ReuskenCB, HaagmansBL, MullerMA, GutierrezC, GodekeGJ, et al. (2013) Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13: 859–866.

54. McMahonHT, GallopJL (2005) Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438: 590–596.

55. SnijderEJ, van TolH, RoosN, PedersenKW (2001) Non-structural proteins 2 and 3 interact to modify host cell membranes during the formation of the arterivirus replication complex. J Gen Virol 82: 985–994.

56. PosthumaCC, PedersenKW, LuZ, JoostenRG, RoosN, et al. (2008) Formation of the arterivirus replication/transcription complex: a key role for nonstructural protein 3 in the remodeling of intracellular membranes. J Virol 82: 4480–4491.

57. BernasconiR, GalliC, NoackJ, BianchiS, de HaanCA, et al. (2012) Role of the SEL1L:LC3-I complex as an ERAD tuning receptor in the mammalian ER. Mol Cell 46: 809–819.

58. RenZ, YanL, ZhangN, GuoY, YangC, et al. (2013) The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease. Protein Cell 4: 248–250.

59. PfefferleS, SchopfJ, KoglM, FriedelCC, MullerMA, et al. (2011) The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog 7: e1002331.

60. de WildeAH, Zevenhoven-DobbeJC, van der MeerY, ThielV, NarayananK, et al. (2011) Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol 92: 2542–2548.

61. DeeksSG, Barre-SinoussiF (2012) Public health: Towards a cure for HIV. Nature 487: 293–294.

62. DelangL, NeytsJ, VliegenI, AbrignaniS, NeddermannP, et al. (2013) Hepatitis C virus-specific directly acting antiviral drugs. Curr Top Microbiol Immunol 369: 289–320.

63. DijkmanR, KoekkoekSM, MolenkampR, SchildgenO, van der HoekL (2009) Human bocavirus can be cultured in differentiated human airway epithelial cells. J Virol 83: 7739–7748.

64. ThielV, HeroldJ, SchelleB, SiddellSG (2001) Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol 82: 1273–1281.

65. ErikssonKK, MakiaD, ThielV (2008) Generation of recombinant coronaviruses using vaccinia virus as the cloning vector and stable cell lines containing coronaviral replicon RNAs. Methods Mol Biol 454: 237–254.

66. TannousBA, KimDE, FernandezJL, WeisslederR, BreakefieldXO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11: 435–443.

67. ZustR, Cervantes-BarraganL, KuriT, BlakqoriG, WeberF, et al. (2007) Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog 3: e109.

68. HertzigT, ScandellaE, SchelleB, ZiebuhrJ, SiddellSG, et al. (2004) Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J Gen Virol 85: 1717–1725.

69. DijkmanR, MulderHL, RumpingL, KraaijvangerI, DeijsM, et al. (2009) Seroconversion to HCoV-NL63 in Rhesus Macaques. Viruses 1: 647–656.

70. ZiebuhrJ, SiddellSG (1999) Processing of the human coronavirus 229E replicase polyproteins by the virus-encoded 3C-like proteinase: identification of proteolytic products and cleavage sites common to pp1a and pp1ab. J Virol 73: 177–185.

71. LundinA, BergstromT, BendriouaL, KannN, AdamiakB, et al. (2010) Two novel fusion inhibitors of human respiratory syncytial virus. Antiviral Res 88: 317–324.

72. Brittain-LongR, NordS, OlofssonS, WestinJ, AndersonLM, et al. (2008) Multiplex real-time PCR for detection of respiratory tract infections. J Clin Virol 41: 53–56.

73. GunsonRN, CollinsTC, CarmanWF (2005) Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol 33: 341–344.

74. KabeyaY, MizushimaN, UenoT, YamamotoA, KirisakoT, et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720–5728.

75. WidehnS, KindblomLG (1990) Agarose embedding: a new method for the ultrastructural examination of the in-situ morphology of cell cultures. Ultrastruct Pathol 14: 81–85.